Complete ABVC Stock Valuation Analysis
Comprehensive intrinsic value analysis using 2 different methodologies
ABVC DCF Analysis
ABVC (ABVC BioPharma, Inc.) discounted cash flow analysis with multiple scenarios, growth assumptions, and terminal value calculations
Financial Projections
| Metrics | 2022 (Historical) | 2023 (Historical) | 2024 (Historical) | 2025 (Projected) | 2026 (Projected) | 2027 (Projected) | 2028 (Projected) | 2029 (Projected) |
|---|---|---|---|---|---|---|---|---|
| Revenue | $969.8K | $152.4K | $508.8K | $636.0K | $795.0K | $993.8K | $1.2M | $1.6M |
| Revenue Growth % | - | -84.3% | 233.8% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% |
| EBIT | $-15.1M | $-8.2M | $-4.7M | $31.8K | $39.8K | $49.7K | $62.1K | $77.6K |
| EBIT Margin % | -1558.5% | -5390.3% | -924.7% | 5.0% | 5.0% | 5.0% | 5.0% | 5.0% |
| Tax Rate % | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% |
| NOPAT | $-11.3M | $-6.2M | $-3.5M | $23.9K | $29.8K | $37.3K | $46.6K | $58.2K |
| NOPAT Margin % | -1168.9% | -4042.8% | -693.5% | 3.8% | 3.8% | 3.8% | 3.8% | 3.8% |
| Capex | $119.7K | $21.2K | $0 | $39.7K | $47.1K | $55.9K | $66.4K | $78.8K |
| Capex / Revenue % | 12.3% | 13.9% | 0.0% | 6.2% | 5.9% | 5.6% | 5.3% | 5.1% |
| Depreciation | $23.8K | $28.5K | $200.9K | $128.6K | $160.8K | $200.9K | $251.2K | $314.0K |
| D&A / Revenue % | 2.5% | 18.7% | 39.5% | 20.2% | 20.2% | 20.2% | 20.2% | 20.2% |
| Change in NWC | $-8.8M | $-1.4M | $-101.9K | $0 | $0 | $0 | $0 | $0 |
| NWC Change / Revenue % | -903.8% | -947.0% | -20.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Unlevered FCF | $-2.7M | $-4.7M | $-3.2M | $112.8K | $143.5K | $182.3K | $231.4K | $293.4K |
| UFCF % Chg. | - | -76.7% | 31.5% | 103.5% | 27.2% | 27.1% | 26.9% | 26.8% |
| FCF / Revenue % | -275.0% | -3091.0% | -634.0% | 17.7% | 18.0% | 18.3% | 18.6% | 18.9% |
| Discount Factor | - | - | - | 0.951 | 0.904 | 0.859 | 0.816 | 0.776 |
| Present Value of FCF | - | - | - | $107.2K | $129.6K | $156.6K | $188.9K | $227.6K |
| Sum of PV of UFCF | - | - | - | $107.2K | $236.9K | $393.4K | $582.3K | $810.0K |
WACC Calculation
Weighted Average Cost of Capital used for discounting cash flows.
| WACC Calculation | Value |
|---|---|
| Cost of Debt | 6.9% |
| Tax Rate | 25.0% |
| After Tax Cost of Debt | 5.2% |
| Risk Free Rate | 4.40% |
| Market Risk Premium | 4.3% |
| Beta | 0.19 |
| Cost of Equity | 5.2% |
| Total Debt | $2.4M |
| Market Cap | $26.7M |
| Total Capital | $29.1M |
| Debt Weighting | 8.4% |
| Equity Weighting | 91.6% |
| WACC | 5.2% |
Terminal Value
Choose between perpetuity growth or exit multiple methods.
| Terminal Value Calculation | Value |
|---|---|
| Terminal Growth Rate | 2.5% |
| Final Year FCF | $293.4K |
| Terminal Value | $11.1M |
| PV of Terminal Value | $8.6M |
| Cumulative PV of UFCF | $810.0K |
| Net Debt | $2.2M |
| Equity Value | $7.3M |
| Shares Outstanding | 12.4M |
| Implied Share Price | $1 |
| Current Share Price | $2 |
| Implied Upside/(Downside) | -62.7% |
Valuation Summary
$0.59
Implied Price
$1.57
Current Price
-62.7%
Upside/Downside
5.2%
WACC
ABVC Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 9 peer companies in Healthcare
P/E Ratio
$0.00
-100.0%
Peer Median: 0.0x
EV/EBITDA
$0.00
-100.0%
Peer Median: 0.0x
P/S Ratio
$0.08
-95.1%
Peer Median: 2.5x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for ABVC's business model and current situation.
Multiple Comparison
| Multiple | ABVC Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -13.0x | 0.0x | 0.0x | -Infinity% | Undervalued |
| EV/EBITDA | Infinityx | 0.0x | 0.0x | Infinity% | Overvalued |
| P/S Ratio | 52.5x | 2.5x | 1.8x | 1958.9% | Overvalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.02B | 0.0x | 0.0x | 0.0x | |
| $0.03B | 0.0x | 0.0x | 1.1x | |
| $0.03B | 0.0x | 0.0x | 0.0x | |
| $0.04B | 0.0x | 0.0x | 107.8x | |
| $0.03B | 0.0x | 0.0x | 52.5x | |
| $0.03B | 0.0x | 0.0x | 62.2x | |
| $0.03B | 0.0x | 0.0x | 2.5x | |
| $0.03B | 0.0x | 0.0x | 0.0x | |
| $0.02B | 0.0x | 0.0x | 22.9x |